Vistagen Therapeutics, Inc.
For the period ended Oct 26, 2026. Filed Oct 30, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 26, 2026 · Filed Oct 30, 2026
VTGN$0.16-0.8%Stored close · as of Nov 6, 2026
Contents
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) of the SECURITIES EXCHANGE ACT OF 1934
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.